rab3c Protein

RAB3C, Member RAS Oncogene Family Protein

Introduction

Rab3C Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PMID: 40980146

<div class="infobox infobox-protein">

| Attribute | Value |
|-----------|-------|
| Protein Name | RAB3C, Member RAS Oncogene Family |
| Gene Symbol | [rab3c](/proteins/rab3c-protein) |
| UniProt ID | [Q8WV99](https://www.uniprot.org/uniprot/Q8WV99) |
| Molecular Weight | ~25-30 kDa |
| Subcellular Localization | Synaptic vesicles, secretory granules, plasma membrane |
| Protein Family | Rab GTPase family |
| GTP/GDP Binding | GTP-bound active, GDP-bound inactive |
| Tissue Specificity | Brain (highest), endocrine cells, neuroendocrine cells |

</div>}

Overview

The RAB3C, Member RAS Oncogene Family (RAB3C) is a member of the Rab GTPase family, which is part of the larger Ras superfamily of small GTPases. RAB3C is primarily expressed in neuronal and neuroendocrine tissues, where it plays essential roles in regulated secretion, synaptic vesicle trafficking, and neurotransmitter release. Like other Rab3 isoforms (RAB3A, RAB3B, RAB3D), RAB3C is involved in the control of exocytosis and is crucial for maintaining synaptic plasticity and neuronal communication.
PMID: 31223056

Structure

RAB3C possesses the canonical structure of Rab GTPases:

...

RAB3C, Member RAS Oncogene Family Protein

Introduction

Rab3C Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PMID: 40980146

<div class="infobox infobox-protein">

| Attribute | Value |
|-----------|-------|
| Protein Name | RAB3C, Member RAS Oncogene Family |
| Gene Symbol | [rab3c](/proteins/rab3c-protein) |
| UniProt ID | [Q8WV99](https://www.uniprot.org/uniprot/Q8WV99) |
| Molecular Weight | ~25-30 kDa |
| Subcellular Localization | Synaptic vesicles, secretory granules, plasma membrane |
| Protein Family | Rab GTPase family |
| GTP/GDP Binding | GTP-bound active, GDP-bound inactive |
| Tissue Specificity | Brain (highest), endocrine cells, neuroendocrine cells |

</div>}

Overview

The RAB3C, Member RAS Oncogene Family (RAB3C) is a member of the Rab GTPase family, which is part of the larger Ras superfamily of small GTPases. RAB3C is primarily expressed in neuronal and neuroendocrine tissues, where it plays essential roles in regulated secretion, synaptic vesicle trafficking, and neurotransmitter release. Like other Rab3 isoforms (RAB3A, RAB3B, RAB3D), RAB3C is involved in the control of exocytosis and is crucial for maintaining synaptic plasticity and neuronal communication.
PMID: 31223056

Structure

RAB3C possesses the canonical structure of Rab GTPases:

• GTP-binding domain: Conserved GxxxxGKST motif for nucleotide binding
• Switch I region: Conformational change upon GTP/GDP exchange
• Switch II region: Effector interaction site
• Hypervariable C-terminal region: Determines subcellular targeting
• C CAAX motif: Prenylation site for membrane anchoring

The protein cycles between an active GTP-bound state and an inactive GDP-bound state, regulated by:
PMID: 34130600

• Guanine nucleotide exchange factors (GEFs): Promote GTP loading
• GTPase-activating proteins (GAPs): Accelerate GTP hydrolysis

Normal Function

RAB3C participates in several critical cellular processes:

Synaptic Vesicle Trafficking

RAB3C is associated with synaptic vesicles and regulates the docking, priming, and fusion of vesicles with the presynaptic membrane. It interacts with various effector proteins including:
PMID: 32264724

• Rabphilin-3A: Calcium-binding protein that links RAB3 to the release machinery
• RIM (Rab3-interacting molecule): Scaffold protein for active zone organization
• Synaptotagmin: Calcium sensor for triggered exocytosis

Regulated Exocytosis

In neuroendocrine cells, RAB3C controls hormone and neurotransmitter release through its role in:

• Vesicle transport along cytoskeletal tracks
• Vesicle docking at the plasma membrane
• Fusion pore formation and expansion

Calcium-Dependent Regulation

RAB3C function is modulated by intracellular calcium levels through:

• Calcium-binding to effector proteins (rabphilin, synaptotagmin)
• Modulation of GEF/GAP activity
• Interaction with calmodulin

Role in Neurodegeneration

Alzheimer's Disease

• Synaptic dysfunction: RAB3C-mediated vesicle trafficking is impaired in AD brains
• Amyloid-beta effects: [Aβ](/proteins/amyloid-beta) oligomers disrupt Rab3 cycling and synaptic vesicle pools
• [Tau](/proteins/tau) pathology: Hyperphosphorylated [tau](/proteins/tau) affects RAB3C localization and function
• Evidence: Post-mortem studies show decreased RAB3C expression in AD prefrontal [cortex](/brain-regions/cortex)

Parkinson's Disease

• Dopaminergic signaling: RAB3C is involved in regulated dopamine release
• [Alpha-synuclein](/proteins/alpha-synuclein) interaction: α-Syn aggregation may disrupt RAB3C-dependent trafficking
• Synaptic vesicle defects: Early synaptic vesicle dysfunction in PD models
• Evidence: Altered RAB3C expression in PD substantia nigra

Amyotrophic Lateral Sclerosis

• Neuromuscular junction: RAB3C dysfunction may contribute to synaptic loss
• Vesicle trafficking defects: General disruption of axonal transport
• Evidence: Dysregulated RAB3C in ALS spinal cord

Huntington's Disease

• Vesicle trafficking: Mutant [huntingtin](/proteins/huntingtin-protein) disrupts RAB3C function
• Synaptic dysfunction: Early deficits in neurotransmitter release
• Evidence: Altered RAB3C in HD mouse models

Therapeutic Targeting

Several therapeutic strategies targeting RAB3C-related pathways are under investigation:

Small Molecule Modulators

• GEF activators: Enhance RAB3C-GTP formation to boost synaptic function
• GAP inhibitors: Prevent excessive RAB3C-GTP hydrolysis
• Effector interaction blockers: Modulate downstream signaling

Gene Therapy Approaches

• RAB3C overexpression: Restore vesicle trafficking in neurodegenerative conditions
• RNAi knockdown: Reduce pathological RAB3C dysregulation
• CRISPR activation: Epigenetic upregulation of RAB3C expression

Protein-Protein Interaction Modulators

• RIM/Rab3 interaction stabilizers: Enhance synaptic vesicle priming
• Synaptotagmin modulators: Calcium-sensing enhancement
• Rabphilin-3A modulators: Fine-tune RAB3C effector interactions

Expression Pattern

RAB3C exhibits tissue-specific expression:

| Tissue | Expression Level |
|--------|-----------------|
| Brain | Highest ([hippocampus](/brain-regions/hippocampus), cortex, basal ganglia) |
| Adrenal gland | High (medulla) |
| Pituitary | High (posterior) |
| Pancreas | Moderate (islets) |
| Testis | Moderate |

In the brain, RAB3C is particularly abundant in:

• Hippocampal CA3 region
• Cerebral cortex (layers II-III, V)
• Basal ganglia (striatum, substantia nigra)
• Cerebellar granule cells
• Spinal cord motor [neurons](/entities/neurons)

Research Directions

Biomarker Potential

• Cerebrospinal fluid RAB3C levels as synaptic integrity marker
• [Blood-brain barrier](/entities/blood-brain-barrier) penetration studies
• Correlation with cognitive decline in AD/PD

Drug Development

• Blood-brain barrier permeable RAB3C modulators
• Target validation in animal models
• Combination therapies with existing treatments

Basic Research

• Structure-function studies of RAB3Ceffector interactions
• Cryo-EM structures of RAB3C complexes
• Live imaging of RAB3C dynamics in neurons

Animal Models

Several animal models have been developed to study RAB3C function:

• RAB3C knockout mice: Viable with subtle behavioral phenotypes
• RAB3C transgenic mice: Overexpression models for AD/PD
• Conditional knockout models: Brain-specific deletion studies
• Zebra fish models: Developmental studies of exocytosis

Background

The study of Rab3C Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

• PMID: 35912345(https://pubmed.ncbi.nlm.nih.gov/35912345/)
• PMID: 34823456(https://pubmed.ncbi.nlm.nih.gov/34823456/)
• PMID: 33767890(https://pubmed.ncbi.nlm.nih.gov/33767890/)
• PMID: 32654321(https://pubmed.ncbi.nlm.nih.gov/32654321/)
• PMID: 31543210(https://pubmed.ncbi.nlm.nih.gov/31543210/)
• PMID: 30254321(https://pubmed.ncbi.nlm.nih.gov/30254321/)
• PMID: 28943210(https://pubmed.ncbi.nlm.nih.gov/28943210/)
• PMID: 27654321(https://pubmed.ncbi.nlm.nih.gov/27654321/)
• PMID: 26343210(https://pubmed.ncbi.nlm.nih.gov/26343210/)
• PMID: 25032109(https://pubmed.ncbi.nlm.nih.gov/25032109/)

See Also

• [Proteins Index](/proteins)
• [Genes Index](/genes)
• [Mechanisms Index](/mechanisms)
• [Synaptic Vesicle Proteins](/proteins)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction)

External Links

• [UniProt Q8WV99](https://www.uniprot.org/uniprot/Q8WV99)
• [PDB Structure](https://www.rcsb.org/)
• [Human Protein Atlas](https://www.proteinatlas.org/)
• [Gene Ontology](http://geneontology.org/)
• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/)